Interactions of endotoxin with human blood cells and serum proteins

References

• Ziegler El, Fisher CJ, Sprung CL, Straube RC, Sadoff JC, Foulke GE, et al. Treatment of Gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. N Eng J Med 1991; 324: 429–36
   PubMed Web of Science ®Google Scholar
• Ruokonen E, Takala J, Kari A, Alhava E. Septic shock and multiple organ failure. Crit Care Med 1991; 19: 1146–51
   PubMed Web of Science ®Google Scholar
• Nathan CF. Secretory products of macrophages. J Clin Invest 1978; 79: 319–26
   Google Scholar
• Beutler B, Milsark IW, Cerami AC. Passive immunization against cachectin/tumor necrosis factor protects mice. from lethal effect of endotoxin. Science 1985; 229: 869–71
   PubMed Web of Science ®Google Scholar
• Morrison DC, Duncan RL, Goodman SA. In vivo biological activities of endotoxin. Prog Clin Biol Res 1985; 189: 31–50
   PubMedGoogle Scholar
• Karim MR, Freudenberg N, Freudenberg MA. Dose related effect of endotoxin on the reticula-endothelial system (RES), the sinusoidal cells in the liver, and on hepatocytes from rats. Second Vienna Shock Forum. Alan R. Liss, New York 1989; 407–412
   Google Scholar
• Northoff H, Berg A, Weinstock C, Baumstark M, Flegel WA. Inhibition of LPS-induced monokine release by human serum and plasma. Pathobiology 1991; 59: 203–4
   Google Scholar
• Freudenberg MA, Bog-Hansen TC, Back U, Galanos C. Interaction of lipopolysaccharides with plasma high-density lipoprotein in rats. Infect Immun 1980; 28: 373–80
   PubMedGoogle Scholar
• Marra MN, Wilde CG, Griffith JE, Snable JL, Scott RW. Bactericidal/pemeability-increasing protein has endotoxin-neutralizing activity. J Immunol 1990; 144: 662–6
   PubMed Web of Science ®Google Scholar
• Tobias PS, Soldau K, Ulevitch RJ. Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum. J Exp Med 1986; 164: 777–93
   PubMed Web of Science ®Google Scholar
• Tobias PS, Mathison JC, Ulevitch RJ. A family of lipopolysaccharide binding proteins involved in responses to Gram-negative sepsis. J Biol Chem 1988; 263: 13479–781
   PubMed Web of Science ®Google Scholar
• Schumann RR, Leong SR, Flaggs GW, Gray PW, Wright SD, Mathison JC, et al. Structure and function of lipopolysaccharide (LPS) binding protein: a plasma protein that controls the response of macrophages to LPS. Science 1990; 249: 1429–31
   PubMed Web of Science ®Google Scholar
• Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD 14 serves as the cellular receptor for complexes of lipopolysaccharide with lipopolysaccharide binding protein. Science 1990; 249: 1431–3
   PubMed Web of Science ®Google Scholar
• Bøyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 1968; 21(97)77–89, Suppl
   PubMedGoogle Scholar
• Yam LT, Li CY, Crosby WA. Cytochemical identification of monocytes and granulocytes. Am J Clin Pathol 1971; 55: 283–90
   PubMed Web of Science ®Google Scholar
• Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally sep arated lipoproteins in human serum. J Clin Invest 1955; 34: 1345–53
   PubMed Web of Science ®Google Scholar
• Ulevitch RJ. The preparation and characterization of a radioiodinated bacterial lipopolysaccharide. Immunochemistry 1978; 15: 157–64
   PubMedGoogle Scholar
• Freudenberg MA. Tumor necrosis factor alpha mediates lethal activity of killed Gram-negative and Gram-positive bacteria in D-galactosamine-treated mice. Infect Immun 1991; 59: 2110–15
   PubMed Web of Science ®Google Scholar
• Ohlsson K, Bjørk P, Bergenfeldt M, Hageman R, Thompson RC. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature 1990; 348: 550–2
   PubMed Web of Science ®Google Scholar
• Heumann D, Gallay P, Barras C, Zaech P, Ulevitch RJ, Tobias PS, et al. Control of LPS binding and LPS induced TNF secretion in human peripheral blood monocytes. J Immunol 1992; 148: 3505–12
   PubMedGoogle Scholar
• Herring WB, Herion JC, Walker RI, Palmer JG. Distribution and clearance of circulating endotoxin. J Clin Invest 1963; 42: 79–87
   PubMed Web of Science ®Google Scholar
• Roth RI, Levin FC, Levin J. Distribution of bacterial endotoxin in human and rabbit blood and effects of stroma-free hemoglobin. Infect Immun 1993; 61: 3209–15
   PubMed Web of Science ®Google Scholar
• Wolff SM. Biological effects of bacterial endotoxin in man. J Infect Dis 1973; 128: 259–64
   PubMedGoogle Scholar
• Elin RJ, Wolff SM, McAdam KPWJ, Chedid L, Audibert F, Bernard C. Properties of reference Escherichia coli endotoxin and its phthalylated derivative in humans. J Infect Dis 1981; 144: 329–336
   PubMed Web of Science ®Google Scholar
• Wolff SM, Rubenstein M, Mulholland JH, Alling DW. Comparison of hematologic and febrile responses to endotoxin in man. Blood 1965; 26: 190–201
   PubMedGoogle Scholar
• Thorne KJI, Oliver RC, MacIntyre DE, Gordon JL. Endotoxin-induced platelet aggregation and secretion. II. Changes in plasma membrane proteins. J Cell Sci 1977; 28: 225–36
   PubMedGoogle Scholar
• Vermylen J, Fumarola D, Semeraro N. The effect of endotoxins on generation of thrombin in the platelet atmosphere [abstract]. Thromb Diath Haemorrh 1975; 34: 315
   PubMedGoogle Scholar
• Morrison DC, Ulevitch RJ. The effects of bacterial endotoxin on host mediation systems. A review. Am J Pathol 1978; 93: 527–616
   Web of Science ®Google Scholar
• Baumberg C, Ulevitch RJ, Dayer JM. Modulation of endotoxic activity of lipopolysaccharide by high-density lipoprotein. Pathobiology 1991; 59: 378–383
   PubMedGoogle Scholar
• Cavaillon JM, Fitting C, Haeffner-Cavaillon N, Kirsch SJ, Warren HS. Cytokine response by monocytes and macrophages to free and lipo-protein-bound lipopolysaccharide. Infect Immun 1990; 58: 2375–82
   PubMedGoogle Scholar
• Munford RS, Hall CL, Dietschy JM. Binding of Salmonella Typhimurium lipopolysaccharides to rat high-density lipoproteins. Infect Immun 1981; 34: 835–43
   PubMed Web of Science ®Google Scholar
• Abdelnoor AM, Harvie NR, Johnson AG. Neutralization of bacteria- and endotoxin-induced hypotension by lipoprotein-free human serum. Infect Immun 1982; 38: 157–61
   PubMed Web of Science ®Google Scholar
• Schlichting E, Henriksen T, Lyberg T. Lipoproteins do not modulate the tissue factor activity, plasmin-ogen activator or tumor necrosis factor production induced by lipopolysaccharide stimulation of human monocytes. Scand J Clin Lab Invest 1994; 54: 465–73
   PubMed Web of Science ®Google Scholar
• Flegel WA, Baumstark MW, Weinstock C, Berg A, Northoff H. Prevention of endotoxin-induced monokine release by human low- and high-density Lipoproteins and by apolipoprotein A-1. Infect Immun 1993; 61: 5140–6
   PubMed Web of Science ®Google Scholar
• Sammalkorpi K, Valtonen V, Kerttula Y, Nikkila E, Taskinen M. Changes in serum lipoprotein pattern induced by acute infections. Metabol Clin Exp 1988; 37: 859–65
   PubMed Web of Science ®Google Scholar
• Wolfe RR, Shaw JHF, Durkot MJ. Effect of sepsis on VLDL kinetics: responses in basal state and during glucose infusion. Am J Physiol 1985; 248: 732–740
   PubMedGoogle Scholar
• Feingold KR, Soued M, Serio MK, Adi S, Moser AH, Grunfeld C. Tumor necrosis factor stimulates hepatic lipid synthesis and secretion. Endocrinology 1989; 124: 2336–42
   PubMed Web of Science ®Google Scholar
• Mama MN, Wilde CG, Collins MS, Snable JL, Thornton MB, Scott RW. The role of bactericidal/ permeability-increasing protein as a natural inhibitor of bacterial endotoxin. J Immunol 1992; 148: 532–537
   PubMedGoogle Scholar
• Shafer WM, Martin LE, Spitznagel JK. Cationic antimicrobial proteins isolated from human neutrophil granubcytes in the presence of düsopropyl fluorophosphate. Infect Immun 1984; 45: 29–34
   PubMed Web of Science ®Google Scholar
• Fisher CJ, Jr, Marra MN, Palardy JE, Marchbanks CR, Scott RW, Opal SM. Humau nutrophil bae tericidal/permeability-increasing protein reduces mortality rate from endotoxin challenge: a placebo controlled study. Crit Care Med 1994; 22: 553–8
   PubMedGoogle Scholar
• Rogy MA, Moldawer LL, Oldenburg HSA, Thompson WA, Montegut W3, Stackpole SA, Kumar A. Anti-endotoxin therapy in primate baoteremia with HA-1A and BPI. Ann Surg 1994; 220: 17–85
   Google Scholar
• Morrison DC. Diversity of mammalian macro-molecules which bind to bacterial lipopolysaccharides. Cellular and molecular aspects of endotoxin reactions, A Nowotny, JJ Spitzer, E Ziegler. Elsevier Science. 1990; 183–189
   Google Scholar